[Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology*; D003523:Cycloserine / Q000494:pharmacology; D003864:Depression, Chemical; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013882:Thiosemicarbazones / Q000494:pharmacology; D014376:Tuberculosis / Q000382:microbiology; D014756:Viomycin / Q000494:pharmacology
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D013882:Thiosemicarbazones; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin; D014756:Viomycin
Lekarstvennaia chuvstvitel'nost' atipichnykh mikobakteriĭ, vydelennykh ot bol'nykh, k proti votuberkuleznym preparatom pervogo i vtorogo riada.